Breaking News, Collaborations & Alliances

Evotec and X-Chem Enter Collaboration Agreement

Aim to accelerate early-stage drug discovery by combining Evotec’s screening platforms and capabilities with X-Chem’s DEL technology.

Author Image

By: Charlie Sternberg

Associate Editor

Evotec SE and X-Chem have entered a collaboration agreement focused on accelerating early-stage drug discovery.   X-Chem’s DNA-encoded library (DEL) technology streamlines hit finding by simultaneously screening up to billions of DNA-tagged compounds, thereby identifying potential start points with high efficiency and precision.   In partnership with Evotec’s screening platforms and capabilities, X-Chem is providing access to its DEL technology, including DELflex, a traditional experimental ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters